Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Grove Biopharma is a biotechnology company offering a materials science solution to peptide therapeutic challenges.
Solu Therapeutics Platform Company that develops antibody-based medicines using a degradable warhead.
Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases
Persist AI is a biotechnology company that builds long-acting microsphere formulations.
Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.
Maxion Therapeutics helps in learning transformative therapies.
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Trans Solutions Research and Resource Center empowers transgender and gender communities.
Revisto is a pioneer AI-powered technology that simplifies the medical, legal, and regulatory review process for pharmaceutical marketing.
TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.
Sunbird Bio is a diagnostics platform developer that aims to give molecular diagnostics with faster outcomes.
Verge Genomics uses machine learning and human genomics to accelerate drug discovery.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
Amprion is a biotech company that focuses on the diagnosis for brain diseases.
Basys.ai automates the process of prior authorization and utilization management for health plans/payers using an AI-based platform.
NanoSyrinx is a discovery stage biotechnology company based at the University of Warwick's Medical School.
OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.
Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.
RetiSpec is a medical imaging startup developing an eye scanner for early detection of Alzheimer's Disease pathology.
Myricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases.
Radar Therapeutics pioneer in treatment modality, precision-expressed mRNA-based therapeutics.
Zephyr AI is a healthcare technology company that reshapes traditional approaches to drug discovery and precision medicine.
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology.
Eli Lilly has invested in 169 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Eli Lilly's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Artificial Intelligence (AI). The firm invests across 22 different industry categories.
Among tracked funding rounds, Aktis Oncology received $175.0M in a Series B round. Eli Lilly's total known invested capital is $11.1B.
Eli Lilly's average investment size is $69.2M across its portfolio of 169 companies.
Recent Eli Lilly portfolio additions include Grove Biopharma, Solu Therapeutics, Augustine Therapeutics, Persist AI, Ampersand Biomedicines. These companies were founded in 2020 or later.